Anthropic's blockbuster IPO is facing early turbulence after the company retracted pricing details circulated to banks. Meanwhile, the FDA is adding new warnings to popular weight-loss drugs, Eli Lilly is reporting promising sleep apnea results, and China’s trade surplus has surpassed $1 trillion. Elsewhere, major healthcare and energy deals are moving forward.

The window is open.

From now through January, the market runs on a schedule. 

Holiday demand hits. 

Fund managers dress up their books.

Fresh January money arrives right on cue. 

The traders who do well in this stretch aren't the smartest in the room. They're the ones who looked early.

The 10 Best Stocks Poised for the Turn of the Year hands you 10 names, the key date for each, the risks that could break the pattern, and real seasonal data.

Free. One sitting. Download Your Guide before the calendar decides for you.

U.S. stock futures are mixed Tuesday as Wall Street pauses following Monday's tech-led rebound. Investors are turning their attention to October's CPI report, which could shape expectations for the Fed's next interest rate move.

Elite Trade Club now offers text alerts — so you get trending stocks and market-moving news sent straight to your phone before the bell.

Email’s great. Texts are faster.

👉 Click here to get our pre-market report to your cell for free!

You’ll be first in line when the market starts moving.

Earnings (Premarket):
TransDigm Group Incorporated [TDG]
· Sea Limited [SE]
· Vodafone Group Plc [VOD]
· Venture Global, Inc. [VG]
· On Holding AG [ONON]

Earnings (Aftermarket):

· Petróleo Brasileiro S.A. Petrobras [PBR, PBR.A]
· Alcon Inc. [ALC]
· Ecopetrol S.A. [EC]
· CoreWeave, Inc. [CRWV]

Economic Events:

· 6:00 AM ET: October NFIB Small Business Optimism Index
· 8:30 AM ET: October CPI and Core CPI (M/M and Y/Y)
· 11:00 AM ET: New York Fed Household Debt and Credit Report
· Throughout the Day: Fed Officials Christopher Waller, Lorie Logan, Jeff Schmid, Michelle Bowman, and Anna Paulson Speak

China's trade surplus topped $1 trillion as October exports surged 35.2%, with booming AI-related shipments driving growth and potentially intensifying trade tensions with Western economies.

Oil prices extended their decline as President Trump signaled restraint toward Iran, with prospects for renewed peace negotiations easing supply concerns and helping stabilize global markets.

Anthropic retracted IPO pricing details suggesting a nearly $70 billion offering, after the information was circulated to banks and subsequently flagged as inaccurate ahead of its anticipated market debut.

Australia announced plans for tougher AI oversight following an OpenAI security incident, with mandatory breach reporting and a dedicated regulator potentially increasing compliance

The FDA ordered new warnings on popular weight-loss drugs over a rare vision-loss risk, with updated labeling required for GLP-1 treatments including Ozempic, Wegovy, and Zepbound.

Eli Lilly's experimental weight-loss pill significantly improved sleep apnea symptoms, with breathing interruptions falling by up to 44% in a late-stage trial ahead of a planned FDA submission.

Wall Street is bracing for the biggest wave of AI IPOs yet, with OpenAI and Anthropic among the names investors are watching.

Get me the power stock.

Money like that does not stay in software. Whatever AI needs in order to run gets a share, and electricity heads that list.

Send me the ticker by text.

One American energy company is already serving that demand. The window closes when the spotlight lands.

Show me the name now.

*This ad is sent on behalf of Guardian Financial Publishing LLC, doing business as Stable Financial Publishing, 1013 Centre Road Suite 403-D, Wilmington, DE 19805. Nothing here is investment, financial, legal, or tax advice, and it is not a recommendation or solicitation to buy or sell any security. Investing involves substantial risk, including loss of principal; past performance does not guarantee future results. Data-center electricity figures are third-party estimates and projections, and AI IPO timing reflects investor expectations, not company guidance. References to OpenAI, Anthropic and Lawrence Berkeley National Laboratory are for informational purposes only; Stable Financial Publishing is not affiliated with, endorsed by, or sponsored by OpenAI, Anthropic or Lawrence Berkeley National Laboratory. Stable Financial Publishing, its owners, employees and contributors may hold positions in securities mentioned and may trade them at any time. Privacy: https://guardian.pub/privacy-policy/ · Terms: https://guardian.pub/terms-of-service/

Surgery Partners received an improved takeover offer worth up to $6 billion, with HealthSpan raising its bid following a competing proposal for the outpatient surgery operator.

Stellantis agreed to sell its shuttered Canadian assembly plant to defense contractor Roshel, with the Brampton facility changing hands amid an ongoing dispute over automotive jobs and production commitments.

The U.S. Senate advanced sweeping legislation to accelerate energy and infrastructure construction, with a bipartisan 73-25 vote moving permitting reforms for power plants, transmission networks, and data centers forward.

NRG Energy agreed to sell six natural gas power plants for $4 billion, with LS Power acquiring 4.9 gigawatts of generation capacity as NRG looks to reduce debt and reward shareholders.

CECO's AI infrastructure business is firing on all cylinders. Shares surged after new orders more than tripled, fueled by demand for power generation and industrial equipment. Its growing $2.2 billion backlog provides strong visibility into 2027, easing concerns that data center investment could be slowing.

QXO's acquisition spree is starting to pay off. Shares climbed after preliminary results exceeded Wall Street expectations, fueled by recent purchases of Kodiak and TopBuild. CEO Brad Jacobs also confirmed he'll remain at QXO while launching a separate $1 billion venture, easing concerns about divided attention.

A promising drug is hitting a commercial reality check. Ionis shares sank after management slashed its Tryngolza sales forecast by roughly half as adoption progresses slower than expected. The setback raises questions about how quickly its growing portfolio of approved treatments can translate into meaningful revenue.

Next-generation geothermal is opening up heat resources once considered too deep or difficult to reach.

The IEA estimates the technical potential of these systems could be enough to meet global electricity demand 140 times over.

Now one analyst is pointing to a company tied to this emerging geothermal story in the American West as drilling technology, federal leasing, and major power buyers push the sector forward.

See the Company Behind This Next-Generation Geothermal Story

That’s all for today. Thank you for reading. If you have any feedback, please reply to this email.

Best Regards,

— Adam Garcia
Elite Trade Club

Click here to get our daily newsletter straight to your cell for free.

P.S. Just like this newsletter, it's 100% free*, and you can stop at any time by replying STOP.